Kymera Therapeutics, Inc. · NASDAQ:KYMR

BVF PARTNERS L P/IL reported a 6.30% stake in Kymera Therapeutics, Inc. (Schedule 13D/A)

Event Jun 26, 2026 · Filed Jun 26, 2026

BVF PARTNERS L P/IL reported a 6.30% stake in Kymera Therapeutics, Inc., 5,237,151 shares, with active intent on Jun 26, 2026. Filed Jun 26, 2026 (Schedule 13D/A).

Stake
6.30%
Shares
5,237,151
Intent
Active
What changed
Stake changed
Filed together
11 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P3.30%2,712,852
BVF I GP LLC3.30%2,712,852
BIOTECHNOLOGY VALUE FUND II LP2.60%2,124,859
BVF II GP LLC2.60%2,124,859
Biotechnology Value Trading Fund OS LP0.40%292,856
BVF Partners OS Ltd.0.40%292,856
BVF GP HOLDINGS LLC5.80%4,837,711
BVF PARTNERS L P/IL6.30%5,237,151
BVF INC/IL6.30%5,237,151
LAMPERT MARK N6.30%5,237,151
Hrustanovic Gorjan0.10%116,190

Source

View original at SEC

Related